INTRODUCTION
The production of glucocorticoids by the adrenal cortex is predominantly regulated by pituitary ACTH (for review see Refs. 1 and 2). This hormone acts via a seven-transmembrane domain receptor belonging to the G protein-coupled receptor superfamily (ACTH-R), also known as the MC2 receptor (3) . The identity of this receptor as the ACTH-R was supported by association of mutations in this receptor and adrenal unresponsiveness to ACTH in familial glucocorticoid deficiency (for review see Ref. 4) . Although it is generally accepted that the ACTH-R is expressed in the adrenal cortex, a number of groups have suggested that the ACTH-R is also expressed in peripheral blood mononuclear leukocytes (5, 6) , adipocytes (7) (8) (9) , and skin (10) on the basis of binding studies and/or mRNA detection. There is very little evidence of ACTH-R expression in other tissues, implying that an effective mechanism exists to restrict expression of this gene.
The most probable explanation for this phenomenon could be the existence of tissue-specific regulatory elements in the ACTH-R promoter. Of particular relevance to ACTH-R expression are several factors that have been shown to be involved in steroidogenic or adrenal-specific expression. The orphan nuclear receptor steroidogenic factor 1 (SF1) is probably the best characterized (11, 12) and has been shown to be involved in steroidogenic cell-specific expression of several genes (13) (14) (15) (16) (17) (18) (19) and in the development of the adrenal and gonad (20) (21) (22) . An adrenal-specific nuclear protein (ASP) has also been shown to be involved in the human CYP21B gene expression (23, 24) . Disruption of the orphan nuclear receptor DAX-1 has been implicated in X-linked adrenal hypoplasia congenita, suggesting a specific role in adrenal and gonadal development (25) . Furthermore, some ubiquitous factors such as NGFI-B (26) and AP1 (27) have been shown to be involved in the regulation of adrenalspecific gene expression.
We have previously reported the cloning and expression of the mouse ACTH-R (28, 29). In this report we describe the characterization of the mouse ACTH-R gene structure and the cloning of its promoter. This promoter has been functionally analyzed in the well characterized Y1 mouse adrenocortical cell line, which has been shown to express the ACTH-R and respond to ACTH (30, 31). Our data indicate the existence of two important regions that regulate tissue-specific expression of the gene. One of these regions suggests a role for SF1, or a closely related protein, in the determination of steroidogenic cell specificity of ACTH-R expression.
RESULTS

Characterization of the Mouse ACTH-R cDNA 5-End
To identify the 5Ј-end of the ACTH-R cDNA and therefore to characterize the structure of the gene, we used the rapid amplification of cDNA ends (RACE) protocol. PCR with a sense primer complementary to the ligated adapter at the cDNA 5Ј-end and an antisense primer complementary to the ACTH-R coding sequence produced a single 1.1-kb fragment (Fig. 1A) . This was subcloned, sequenced, and shown to comprise the ACTH-R coding sequence and a 5Ј-untranslated sequence of 241 bp (Fig. 1B) . Comparison between this cDNA fragment and the ACTH-R genomic sequence indicated that the mouse ACTH-R gene consisted of at least two exons with an intron/exon junction 96 bp upstream of the translation start codon (Fig. 1B) . The exonic nature of the sequence was confirmed using S1 nuclease protection assay (32) with mouse adrenal mRNA and a genomic probe spanning the putative intron/exon junction in which only the predicted exonic sequence was protected against S1 nuclease digestion. Another probe derived from the 5Ј-RACE cDNA product was fully protected against digestion (data not shown).
Tissue-Specific Distribution of ACTH-R mRNA
Taking advantage of the multiexonic nature of the ACTH-R gene, we used RT-PCR with intron-skipping primers to assess ACTH-R expression in mouse adrenal gland, liver, lung, spleen, abdominal adipose tissue, whole brain, heart, testis, and kidney. The PCR products were analyzed by Southern blotting with the RACE cDNA fragment described above as the probe to obtain the maximum sensitivity. RNA quality and the efficiency of the reverse transcription step were controlled by carrying out parallel RT-PCR with ␤-actin primers. As shown in Fig. 2 , the ACTH-R mRNA was relatively abundantly expressed in adrenal tissue. However, low expression of this gene was also apparent in abdominal adipose tissue. Expression could not be detected in spleen, testis, liver, lung, heart, whole brain, or kidney.
Cloning of the Mouse ACTH-R Gene Promoter
A probe corresponding to the first 144 bp of the 5Ј-end of the RACE product was used to screen 10 6 pfu of a mouse genomic library under high stringency conditions. Five positive clones were isolated that were found to have distinct restriction patterns after digestion with Bgl2, NcoI, and PvuII and Southern blot analysis using the same probe as for the screening (Fig. 3) . The restriction fragments marked with arrows in the figure were subcloned and sequenced. In this way the 5Ј-untranslated region was shown to consist of two separate exons. Exon 1 overlapped the 5Ј-end of the RACE clone by 33 bp. Exon 2 consisted of 112 bp, which together with the 96 bp at the 5Ј-end of exon 3, encode the 5Ј-untranslated region of this gene. The genomic clones 4 and 5 contained exon 2 while clones 1, 2, and 3 contained exon 1. The NcoI-positive fragment from clone 1, containing exon 1, was subcloned, sequenced, and shown to contain 1.8 kb upstream sequence expected to be the mouse ACTH-R promoter. This fragment was therefore analyzed further.
The precise size of exon 1 was assessed by S1 nuclease protection assay with mouse adrenal mRNA and a probe spanning the expected transcription start site. It was demonstrated that the actual size of the first exon is 113 bp (Fig. 4) . There was a second protected fragment corresponding to an exon of 109 bp implying that there were two major start sites for transcription separated by 4 bp. The intensity of these two protected fragments was similar, indicating that both transcription start sites are used with equivalent efficiency.
Sequencing of the 5Ј-untranslated region (Fig. 5 ) did not reveal any of the classic promoter features such as a TATA box, CAAT box, or GC-rich region. However, there is an initiator-like sequence overlapping the transcription start site (dashed underlining in Fig. 5) , and there are a number of consensus response elements as depicted in Fig. 5 including an OctB site, an Sp1 site, a glucocorticoid response element, an AP2 site, an AP1 site, and two SF1-like sites at positions Ϫ897 bp and Ϫ25 bp, respectively.
Functional Characterization of the Mouse ACTH-R Promoter
To functionally characterize the promoter, the region between ϩ104 bp and Ϫ1808 bp was subcloned into the pGL3-basic luciferase reporter vector. This construct was then transfected by electroporation into mouse Y1 adrenocortical cells and two other mouse cell lines derived from tissues that do not express ACTH-R: TM3 cells, derived from Leydig cells, and L cells, a fibroblast cell line. With this full length promoter construct, luciferase activity was detectable in Y1 cells, but no activity was apparent in TM3 cells. The level of this activity was equivalent to 5-10% of the activity of Rous sarcoma virus (RSV).luciferase in the same cells. L cells produced some activity, although this was extremely low and statistically indistinguishable from zero ( Fig. 6A) , showing the expected cellspecific activity of this promoter.
To identify the important regulatory regions for expression of the ACTH-R gene, a series of deletion constructs of the promoter were generated as indicated in Fig. 5 . Figure 6A summarizes the effect of these deletions on luciferase reporter activity in the three cell lines. There was no significant difference between the full length [p(1808)] construct and all the other deletions up to Ϫ113 bp in Y1 cells. No significant luciferase activity was detected for any of the constructs in L cells. In TM3 cells no luciferase activity was detected after transfection with the full length construct or the two constructs p(1590) and p(1236). In contrast, when the deletion constructs p(908), p(717), p(641), and p(113) were transfected, they all showed luciferase activity in TM3 cells at a significantly lower level than in Y1 cells with the exception of A, Ethidium bromide-stained agarose gel analysis of RT-PCR performed with ␤-actin exon-skipping primers and 10 g total RNA obtained from the mouse tissues indicated, or a water control (Ϫ) to check the RNA quality and the reverse transcription efficiency. B, RT-PCR was performed with the mouse ACTH-R intron-skipping primers and the same RNA samples, and the product was analyzed by Southern blotting after agarose gel electrophoresis using the mouse ACTH-R 5Ј-RACE cDNA fragment as the probe. p(113), which appeared to induce transcription at an equivalent level to the minimal promoter in Y1 cells.
Identification of a Binding Site for SF1
Of the transcription factor consensus binding motifs identified, the SF1-like sequence at position Ϫ25 bp was of particular interest in connection with ACTH-R tissuespecific expression because it is the only recognized site in the construct p(113) that showed promoter activity specifically in Y1 cells and TM3 cells. We therefore used site-directed mutagenesis to alter the Ϫ25 SF1 consensus sequence in the p(113) construct at two critical nucleotides' SF1 binding site (AAGGTT 3 ATTGTT). The results of an independent series of experiments performed in Y1 cells are shown in Fig. 6B and indicate a highly significant loss of promoter activity in p(113)mutant to 38% of that of p(113) itself (P Ͻ 0.01).
Further evidence for the involvement of SF1 at the Ϫ25-bp site was sought using gel shift analysis. A 46-bp fragment surrounding the SF1-like binding site at position Ϫ25 bp was used as the labeled probe (see Fig. 7A ). A DNA/protein complex (CI) was found to be formed using cellular extracts from Y1 cells. A similar complex was apparent when a cellular extract from TM3 cells was used. However, no such complex was observed with extracts from L cells (Fig. 7B) , although a certain amount of very slowly migrating nonspecific material was present. In Y1 cell extracts a second complex (CII) was also formed. Specificity of the interaction was confirmed by displacement of the DNA/ protein complexes by a 200-fold molar excess of an unlabeled consensus SF1-binding site derived from the rat CYP17 gene (19) , providing further evidence that the protein involved in these complexes was SF1 (Fig. 7B ).
SF1 Induces ACTH-R Promoter Activity in Fibroblasts
To confirm the functional relevance of SF1 in the regulation of ACTH-R expression, an expression vector containing the SF1-coding sequence was cotransfected with the promoter construct p(908) into L cells.
Fig. 4. ACTH-R Gene Structure and 5Ј-End Determination
A, Schematic representation of the ACTH-R gene, the genomic clones from which each exon was identified, the mature mRNA product, and the site and extent of the 5Ј-RACE cDNA clone. B, Determination of the transcription start site by S1 nuclease protection assay. A probe overlapping the putative transcription start site was obtained as described in Materials and Methods. The protected fragments of 104 bp and 100 bp marked with the bottom arrows indicate two transcription start sites corresponding to first exons of 113 bp and 109 bp, respectively. The undigested probe of 300 bp is marked with the top arrow. The (Ϫ) lane indicates the use of 10 g of transfer RNA as template. P(908) was chosen to avoid any influence of the putative repressor identified in TM3 cells in case it was also present in L cells. These cells do not express SF1 endogenously, as shown above (Fig. 7B) , and do not have any ACTH-R promoter activity (Fig. 6A) . Heterologous expression of SF1 in these cells resulted in significant induction of ACTH-R promoter activity (P Ͻ 0.05) whereas no effect was observed using a promoterless construct (Fig. 8) , lending support to the hypothesis that SF1 is an essential factor for ACTH-R expression.
DISCUSSION
We have demonstrated that the mouse ACTH-R gene consists of at least three exons of lengths 113 bp, 112 bp and Ͼ1000 bp. The two first exons contain the 5Ј-untranslated region while the third exon contains 96 bp of 5Ј-untranslated region and the entire coding sequence. The functional relevance of the two untranslated exons is not known. Interestingly, a single exon upstream of the coding exon has been identified in the human ACTH-R gene (33), and this is highly homologous to the mouse exon 1, suggesting that any physiological role of the mouse exon 2 is not required in the human gene.
The knowledge of this structure has enabled us to use RT-PCR as a highly sensitive method of mRNA detection with intron-skipping primers followed by Southern blotting. As shown in Fig. 3 , ACTH-R mRNA is relatively abundantly expressed in the adrenal gland, as is well recognized. However, there is also low expression in abdominal adipose tissues. This site has already been shown to express ACTH-R by binding studies, and recently this has been confirmed by Northern blot analysis (9) and has been proposed to mediate the lipolytic action of ACTH. Thus, our data confirm the tissue-specific nature of ACTH-R gene expression, and it is the molecular mechanism of this regulation, especially at the level of the adrenal cortex, that has been the focus of our further studies. It is of interest that an abstract recently presented by another group (34) indicated the existence of a fourth alternatively spliced exon lying between exons 1 and 2. This is probably an uncommon splice variant that we have been unable to identify but may be represented by the weak higher molecular weight band in the adrenal RT-PCR shown in Fig. 2B .
Sequence analysis of the 5Ј-untranslated flanking region of the ACTH-R gene indicated that the region immediately upstream of exon 1 does not show any typical characteristics of promoter regions such as a TATA box, CAAT box, or GC-rich region. However, there is an initiator-like site overlapping the transcription start site. The initiator element (Inr), first identified for viral transcriptional regulation (for review see Ref. 35 ), has been shown to be involved in transcription initiation of a growing number of TATA box-containing and TATA-less promoters. In addition to this Inr-like sequence, there are several putative sites for transcription factors as shown in Fig. 5 . Of particular interest is the presence of a partial consensus sequence at position Ϫ25 bp for binding of the mouse transcription factor SF1, which has been shown to be involved in tissue-specific expression of several steroidogenic enzymes (11) (12) (13) 20) as well as Mullerian-inhibiting substance (15) , and the glycoprotein hormone ␣-subunit (16). SF1 has also been shown to be involved in the cAMP responsiveness of the cytochrome P450c17 enzyme expression (19) . Therefore, this sequence motif represents a strong candidate for regulation of ACTH-R gene expression. Recently, Naville et al. (33) have reported the promoter sequence for the human ACTH-R gene revealing that it also contains an Inr element and an SF1-like site at position Ϫ35.
The presence of a glucocorticoid response element in the ACTH-R promoter is also important because glucocorticoids have been shown to induce a significant increase of ACTH-R expression in ovine adrenocortical cells (36). The molecular mechanism of this effect is not yet known but may occur at the transcriptional level. It is noteworthy that the ACTH-R promoter does not contain any consensus cAMP response element (CRE) despite the fact that ACTH is recognized to stimulate ACTH-R expression via cAMP (31, 37). However, this lack of a consensus CRE is a common feature for the cAMP-regulated steroidogenic en- zymes and may suggest the existence of a yet uncharacterized cAMP-dependent regulatory factor. In the case of CYP17, this function has been shown to be fulfilled by SF1 (19) , but that does not seem to be the case for the other steroidogenic enzymes. The functional importance of both of these regulatory elements will be addressed in our future work. In contrast, the human ACTH-R contains seven CRE-like elements in the proximal 700 bp of this promoter, although these have not yet been shown to be functional (33).
The promoter activity of the ACTH-R 5Ј-untranslated region was assessed after insertion upstream of the luciferase coding sequence in the pGL3 basic vector. It has been shown that this DNA fragment is necessary and sufficient to drive expression of a heterologous gene in a cell-specific manner, since the signal was detectable in Y1 cells but not in TM3 or L cells. Deletion studies allowed us to define two important regions for cell-specific expression. Promoter activity became detectable in TM3 cells when sequences upstream of position Ϫ908 bp were removed, despite remaining undetectable in L cells (Fig. 6A) . These results suggest that the ACTH-R promoter is potentially active in steroidogenic tissues other than the adrenal, but is totally inhibited by the binding of a factor between position Ϫ1236 bp and Ϫ908 bp that would act as a repressor of expression in nonadrenal steroidogenic cells such as the Leydig cell. The existence of such transcriptional repressors or silencers responsible for tissue-specific expression of genes has been reported for several genes. However, our results are the first evidence for a repressor restricting gene expression in the adrenal gland.
In Y1 and TM3 cells, the minimal promoter extended to Ϫ113 bp, which includes the putative SF1-like binding site described earlier. This suggests that SF1 might be a strong candidate for determining steroidogenicspecific expression of the ACTH-R as it does for several other genes. Our data lend support to the notion that SF1 or an SF1-like factor is involved in ACTH-R cell-specific regulation since 1) Mutation of the SF1 site leads to significant loss of promoter activity; 2) it binds specifically to this site as shown by gel shift analysis; and 3) expression of SF1 in a cell line that normally does not have any ACTH-R promoter activity leads to an induction of its activity. However, the level of promoter activity obtained in these conditions is low, indicating that SF1 may be essential to induce the promoter in an "active conformation" whereas other factors are probably necessary for full promoter activity. In keeping with this, it is noteworthy that mutation of the SF1 site leads only to a significant reduction of activity and not complete loss of promoter function. The role of the second SF1-binding site at position Ϫ897 bp has not been extensively studied. However, it seems that SF1 binding at this site of the promoter may be more critical in TM3 cells than in Y1 cells because its absence in both constructs p(717) and p(641) resulted in a significant decrease of promoter activity in TM3 cells whereas it was almost without effect in Y1 cells. The significance of these results will need further investigation.
In conclusion, the tissue-specific expression of the ACTH-R gene appears to be mainly under the control of two factors, with SF1, or an SF1-like factor, responsible for steroidogenic cell specificity, and another as Five micrograms of the promoterless luciferase reporter plasmid pGL3 or the ACTH-R promoter-luciferase construct p(908) were cotransfected with or without the SF1 expression vector under the control of a cytomegalovirus promoter, and luciferase activity was measured after 72 h as described earlier. The results are the mean (ϮSEM) of three independent experiments. The asterisk represents a significant increase (P Ͻ 0.05) using one-tailed Student's test. yet unknown factor binding between position Ϫ1236 bp and Ϫ908 bp silencing the promoter in nonadrenal steroidogenic cells. It might be postulated that binding of such a repressor protein upstream of the SF1-binding site prevents the formation of an SF1-dependent transcriptionally active complex.
MATERIALS AND METHODS
Chemicals
All chemicals were obtained from Sigma Chemical Co. (Poole, Dorset, UK); FCS, horse serum, Ham's F10 and F12 media were obtained from GIBCO BRL (Renfrewshire, UK). All radionucleotides were obtained from Amersham International plc (Amersham, Bucks. UK).
Rapid Amplification of cDNA Ends
The Marathon cDNA Amplification kit (Clontech, Cambridge, UK) was used following the manufacturer's protocol. The mouse ACTH-R gene antisense primer was 5Ј-GACCTG-GAAGAGAGACATGTAG3-Ј. RNA was extracted from mouse adrenal tissues using RNazolB (Biogenesis, Poole, Dorset, UK), and mRNA was purified using a Sephadex oligo-dT column (Pharmacia, Herts, UK). One microgram of this mRNA was used per reaction. The PCR product was subcloned directly in the pGEM-T vector (Promega, Southampton, UK) and sequenced using sequenase 2.0 (Amersham).
RT-PCR
Ten micrograms of total RNA from the following frozen mouse tissues were analyzed: whole brain, kidney, lung, spleen, abdominal adipose tissue, lung, adrenal, heart, and testis. One hundred nanograms of oligo-dT were used to prime the Superscriptase (GIBCO BRL) for 1 h at 42 C in a 20-l reaction mixture. One microliter was used as template for PCR with: mouse ACTH-R exon 1 sense primer: (5Ј-CTTGCCGAGAAAGATCCT-3Ј) and exon 3 antisense primer: (5Ј-AGCGATGTGAAGGTGAGC-3Ј), or the ␤-actin sense primer: (5Ј-GTAACCAACTGGGACGAT-3Ј) and antisense primer (5Ј-GACCACACCCCACTATGG-3Ј).
Reaction conditions were 30 sec at 94 C and 30 sec at 56 C for ACTH-R or 58 C for ␤-actin and 1 min at 72 C for 30 cycles.
In the case of the ACTH-R, PCR products were run on a 1% agarose gel, transferred to nitrocellulose membrane, and hybridized in 50% formamide, 5 ϫ NaCl-sodium citrate, 0.05 M sodium phosphate buffer (pH 6.8), 0.3 mg/ml herring sperm DNA, 5 ϫ Denharts solution, 0.05% SDS, with approximately 10 6 cpm ␣-32 P-labeled ACTH-R probe at 42 C for 16 h. The filters were washed under stringent conditions (1 ϫ NaClsodium citrate, 0.1% SDS) at 65 C and exposed to Kodak XAR-5 film (Eastman Kodak, Rochester, NY) at Ϫ80 C for 3 h or overnight for the long exposure.
S1 Nuclease Protection Assay
The reaction conditions were as described previously (32). PCR was performed with a biotinylated sense primer MP237S: 5Ј-TACAACCTTCACAATCTGC-3Ј designed in the putative promoter region and a phosphorylated antisense primer at the 3Ј-end of exon 1: 5Ј-CTGAAGTAGGATCTT-TCTCG-3Ј. Fifty micrograms of total mouse adrenal RNA were hybridized with this probe overnight at 43 C.
Plasmid Constructs
For the full-length construct p(1808), PCR was performed using Vent polymerase (New England Biolabs., Beverly, MA) with a sense primer: 5Ј-GACCATTAACTTTGAATTAGG-3Ј at the 5Ј-end of the NcoI fragment and an antisense primer complementary to exon 1: 5Ј-CTGAAGTAGGATCTT-TCTCG-3Ј using the genomic positive clone 1 as template. This was subcloned into the SmaI site of the pGL3-basic luciferase reporter vector (Promega, Madison, WI), and PCR artefacts were excluded by sequencing. For the promoter deletions, p(1808) was digested with specific enzymes as follows: Ϫ1590 bp, KpnI; Ϫ1236 bp, NheI; after separation of the insert and the backbone, the plasmid was religated on itself. For the following deletions, p(1808) was cut with KpnI and another specific enzyme, the ends were filled using Klenow fragment, and the plasmid was religated: Ϫ908 bp, Bsg1; Ϫ717 bp, TthIII.1; Ϫ641 bp, ApaI; Ϫ113 bp, BstX1. The constructs or at least their 5Ј-extremities were checked by sequencing.
Cell Culture and Transfection Experiments
Mouse Y1 adrenal cells were maintained in 50% DMEM and 50% Ham's F10 supplemented with 12.5% horse serum and 2.5% FCS. Mouse TM3 cells (kindly provided by Dr Ray Iles) were grown in 50% DMEM and 50% Ham's F12 supplemented with 5% horse serum, 2.5% FCS, and 20 mM HEPES (pH 7.4). Mouse L cells (kindly given by Prof. Tom MacDonald) were grown in RPMI containing 5% FCS. Approximately 10 6 cells were washed and resuspended in HEPESbuffered saline and 500 l were used per electroporation at 300 V and 1000 milliFarads in 2-mm wide cuvettes with 5 g of the ACTH-R gene construction and 10 g of RSV-CAT plasmid. Cells were left 1 min at room temperature and then resuspended in their respective growth medium in 60-mm plates for 72 h. Five micrograms of SF1 expression vector were cotransfected with 5 g of the p(908) construct in L cells in the conditions described above. Because the transfection efficiency was constant, RSV-CAT was not used systematically in all experiments.
Luciferase Activity and Chloramphenicol Acetyltransferase (CAT) Protein Measurement
The luciferase assay kit (Promega) was used for this purpose. The cells were washed twice at room temperature with PBS, covered with 400 l lysis reporter buffer for 20 min at room temperature, scraped, recovered in Eppendorf tubes, and snap frozen at Ϫ70 C. The cell debris was pelleted and 100 l of the supernatant were used for luciferase activity measurement with 400 l lysis reporter buffer and 100 l luciferase substrate solution. One hundred fifty microliters of the supernatant were used for measurement of CAT protein level according to the CAT ELISA protocol (Boehringer Mannheim, Lewes, UK). Mutagenesis of the Ϫ25 bp site in the p(113) plasmid was accomplished using the QuikChange technique (Stratagene Ltd., Cambridge, UK) with Pfu polymerase. The identity of mutated clones was determined by DNA sequencing.
Electrophoretic Mobility Shift Assay
To prepare the probe an antisense ACTH-R primer, 5Ј-GA-CAGCTACTTGTTATCC-3Ј, was labeled with [␥ 32 P]ATP using T4 polynucleotide kinase (New England Biolabs.) and used for PCR with an unlabeled ACTH-R sense primer, 5Ј-CCGTT-TATTTCTAGTGAC-3Ј producing a 46-bp fragment surrounding the SF1-like site, which was purified with microcentrifuge 5000 tubes (Sigma). Binding reactions of 10 l were carried out in buffer containing 15 mM HEPES, 75 mM KCl, 9 mM MgCl 2 , 0.075 mM EDTA, 12.5% glycerol, 1 mM dithiothreitol, 0.1 mg/ml sperm DNA, approximately 5 ϫ 10 3 cpm of radiolabeled probe, and 30 mg of cellular extracts proteins for the three cell lines prepared as described previously (36). The reactions were incubated for 15 min at 30 C. Competitor was added 15 min before the probe and incubated at 30 C. Free and bound DNA were separated on a 4% nondenaturing polyacrylamide gel in 0.5 ϫ Tris-borate-EDTA at 4 C. The gels were dried and analyzed by autoradiography. 
